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Abstract
Cryptorchidism (undescended testes) is among the most common congenital diseases in male chil-
dren. Although many factors have been linked to the incidence of cryptorchidism, and testicular 
androgen plays a key role in its pathogenesis, the cause remains unknown in most cases. Recently, 
a Japanese group published a speculative paper entitled, “Nationwide increase in cryptorchidism af-
ter the Fukushima nuclear accident.” Although the authors implicated radionuclides emitted from 
the Fukushima accident as contributing to an increased incidence of cryptorchidism, they failed to 
establish biological plausibility for their hypothesis, and glossed over an abundance of evidence and 
expert opinion to the contrary. We assessed the adequacy of their study in terms of design setting, 
data analysis, and its conclusion from various perspectives. Numerous factors must be considered, 
including genetic, environmental, maternal/fetal, and social factors associated with the reporting of 
cryptorchidism. Other investigators have established that the doses of external and internal radia-
tion exposure in both Fukushima prefecture and the whole of Japan after the accident are too low to 
affect testicular descent during fetal periods ; thus, a putative association can be theoretically and 
empirically rejected. Alternative explanations exist for the reported estimates of increased crypt-
orchidism surgeries in the years following Japan’s 2011 earthquake, tsunami, and nuclear cri-
sis. Data from independent sources cast doubt on the extent to which cryptorchidism increased, if 
at all. In any case, evidence that radionuclides from the Fukushima Daiichi Nuclear Power Plant 
could cause cryptorchidism is lacking.
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Introduction 
Cryptorchidism, the failure of one or both tes-
tes to descend into the scrotum, is among the most 
common congenital diseases in boys. In utero, tes-
ticular descent occurs in two phases : transabdomi-
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nal and inguinoscrotal1). The testis finishes trans-
abdominal descent by 10 weeks’ gestation, and 
passes through the inguinal canal toward the scro-
tum between 20 and 28 weeks’ gestation (inguino-
scrotal phase). Testicular descent is usually com-
pleted before birth (around 35 weeks’ gestation)2,3). 
Androgen levels, especially testosterone secreted by 
Leydig cells, peaks between 14 and 17 weeks’ gesta-
tion2). In most cases of cryptorchidism, the testis 
locates between the internal inguinal ring and the 
scrotum, owing to some disturbance in the andro-
gen-dependent inguinoscrotal phase. Indeed, an-
drogen blockage during the inguinoscrotal phase in-
duces cryptorchidism in animal studies1). Recent 
reports have described the association between 
pathogenetic mechanisms for cryptorchidism and 
genetic, environmental, and maternal/fetal fac-
tors3) ; despite this, the cause of cryptorchidism re-
mains unknown in most cases.
Environmental endocrine disrupters (EEDs), a 
group of compounds with potentially adverse health 
effects, are thought to be associated with cryptorchi-
dism. EEDs can be found in foods, packaging, and 
pesticides, and some EEDs inhibit the normal func-
tion of androgen in animal studies. Although ex-
perimental studies using animal models have provid-
ed support for the hypothesis that EEDs impact on 
human fetal testicular descent and cryptorchidism, 
as yet there is insufficient evidence to conclusively 
implicate EEDs in cases of human cryptorchidism3). 
A recent publication by Murase et al., “Nation-
wide increase in cryptorchidism after the Fukushima 
nuclear accident,” suggests that radionuclides emit-
ted from the Fukushima Daiichi Nuclear Power Plant 
could be a major cause of increased cryptorchidism4). 
However, numerous limitations of their study impair 
the authors’ credibility. Herein, we first summarize 
global trends pertaining to cryptorchidism. We 
then review known effects of radiation exposure on 
testicular function, spermatogenesis, and steroido-
genesis in order to determine if and when radiation 
could plausibly interfere with testicular descent. 
Finally, we consider whether or not cryptorchidism 
anywhere in Japan increased after Japan’s earth-
quake, tsunami, and nuclear crisis, and whether the 
dispersion of radionuclides could be implicated.  
1. Trends in the rates of cryptorchidism 
around the world
Various epidemiological surveys have reported 
changes in the prevalence of cryptorchidism. Some 
older surveys, before the 1980s, reported prevalenc-
es of cryptorchidism increasing year by year. Chil-
vers et al. reported that the annual number of hospi-
tal patient discharges including a diagnosis of 
cryptorchidism had risen by a factor of 2.3 in the Ex-
amination of Hospital Inpatient Enquiry data for 
England and Wales over the years 1962-19815). 
Campbell et al. studied trends in hospital discharges 
of patients with cryptorchidism in Scotland from 
1961 to 1985 and found substantial increases in the 
discharge of boys with cryptorchidism in different 
age groups6). The John Radcliffe Hospital Cryptor-
chidism Study Group examined a total of 1,849 boys 
born to mothers residing in a defined area around 
Oxford and showed that the cryptorchidism rate had 
apparently increased by 65% over two decades, in 
contrast to a concurrent doubling of the national or-
chidopexy rate7). 
Other surveys before and after the 1980s re-
ported that the prevalence of cryptorchidism did not 
always increase. Paulozzi examined data from a 
larger number of countries participating in the Inter-
national Clearinghouse for Birth Defects Monitoring 
Systems to address the question of whether cryptor-
chidism increased worldwide between the 1960s and 
the 1990s8). They reported clear increases in two 
U.S. systems and in the South American system, but 
not in seven other systems elsewhere8). Richiardi 
et al. analyzed Swedish trends in orchiopexy rates 
using data from the Swedish Hospital Discharge 
Register between 1977 and 1991 and reported that 
the prevalence of cryptorchidism decreased in Swe-
den starting from the early 1980s9). Toledano et al. 
examined the number of orchiopexy procedures us-
ing routine hospital admission data for England, 
Wales, and Scotland for the fiscal years 1992-1993 
through 1998-1999 and showed that the orchiopexy 
rates for boys 0-14 years old fell by 33% between 
1992 and 199810). Cappello et al. examined all or-
chiopexies performed between 1984 and 2002 using 
the New York State Statewide Planning and Re-
search Cooperative System database and demon-
strated that although the annual number of orchio-
pexies exhibited some fluctuation, there was no 
significant trend during the study period11). A more 
recent report showed year-to-year variation, but no 
increase in the prevalence of cryptorchidism over a 
26-year period, using data obtained from the Nova 
Scotia ATLEE Perinatal Database of all live births in 
Nova Scotia, Canada since 198812). Thus, some 
previous studies have reported an increasing preva-
lence over time, whereas others have not, or have 
reported no significant trends of prevalence. Such 
variation calls attention to difficulties of design and 
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execution in epidemiological surveys of cryptorchi-
dism. Indeed, the use of orchiopexy rates to mea-
sure the prevalence of cryptorchidism has funda-
mental limitations because the number of orchiopexies 
does not always directly correlate with the incidence 
of cryptorchidism.
Murase et al. cited an incidence of cryptorchi-
dism at 1 year of age as 1.0%-1.7% according to Jap-
anese guideline for diagnosis and treatment of crypt-
orchidism published in 2005. They also estimated 
that 5,000-8,500 surgeries will be required annually, 
given that approximately 500,000 males are born in 
Japan every year4). However, the data do not nec-
essarily align with the actual incidence of cryptorchi-
dism in Japan. While citing Japanese guidelines13), 
the incidence range of 1.0%-1.7% is from referenc-
es14-18) pertaining to Western people rather than Jap-
anese. There are no similar reports on the inci-
dence of cryptorchidism based on a national survey 
of Japanese people. 
2. Effects of radiation on  
testicular function
Rodent studies indicate that mammalian testes 
are sensitive to radiation19). Testicular function in-
cludes spermatogenesis and steroidogenesis, and 
the impairment of testicular function can result in 
male infertility and abnormality of both internal and 
external development, such as cryptorchidism and 
hypospadias. Therefore, when the effects of radia-
tion on testicular function are discussed, spermato-
genesis and steroidogenesis should be considered 
individually. 
Although high-dose radiation exposure in ani-
mals, and radiation therapy in humans, can affect 
testicular function, both spermatogenesis and ste-
roidogenesis are dose-dependent to different de-
grees. Although high-dose radiation exposure can 
impair steroidogenesis in adults, there is no evi-
dence that it can affect testicular descent during the 
fetal period.
1) Radiation and spermatogenesis
(1) Effects of radiation on spermatogenesis
Radiation deletes germ cells and can result in 
permanent azoospermia, suggesting that it can lead 
to male infertility20). There is also some evidence 
of association between radiation exposure and the 
impairment of spermatogenesis in rodents and hu-
mans. 
Animal studies
Delic et al. reported that spermatogenic damage 
was observed after doses of 3-5 Gy but not after 
doses of 0-2 Gy to adult rat testes21). Furthermore, 
Shetty et al. reported that irradiation with 6 Gy 
caused a complete block of spermatogonia differenti-
ation in LBNF1 rats22). Among non-human pri-
mates, macaques have the most histologically simi-
lar testes to humans, and showed a disturbance of 
spermatogenesis after 2 or 4 Gy that lasted 6 
months until recovery, with incomplete recovery 
even after 18 months23-25). Foppiani et al. evaluated 
the effect of bilateral testicular irradiation (2 Gy) on 
testicular volume and sperm parameters in adult cy-
nomolgus monkeys26) and reported a decrease in 
testicular volume and sperm count after irradiation.
Human studies
Testicular injury is common following radio-
therapy in humans, and patients often suffer from 
azoospermia or male infertility. Moreover, testicu-
lar x-irradiation results in the suppression of sperm 
counts in humans27). Compared to the mouse, 
spermatogenesis in man is approximately 3.1 times 
more sensitive to ionizing irradiation27). A single 
exposure of the testis to ionizing radiation at dose 
levels of 6 Gy or below can cause significant distur-
bance of spermatogenesis28). A dose of 0.15 Gy 
leads to a significant decrease in semen volume, and 
0.3-0.5 Gy causes temporary oligospermia29). 
Speiser et al. assessed ten patients who received 
daily testicular doses of 0.12 Gy for a total dose of 
1.4-3.0 Gy ; all such patients had azoospermia, but 
only two of them for longer than 16 months30). De 
Felice et al. reported that doses of irradiation > 0.35 
Gy caused azoospermia, which was reversible in 
some cases31). The time taken for recovery in-
creases with larger doses ; complete recovery takes 
place within 9-18 months following radiation with 
< 1 Gy, but doses in excess of 2-6 Gy may result in 
permanent azoospermia31). According to the Inter-
national Atomic Energy Agency (IAEA), a dose of 1.0 
Gy leads to a temporary reduction in the number of 
spermatozoa, that of 1.5 Gy leads to temporary ste-
rility, and that of 5.0 to 6.0 Gy (acute) can produce 
permanent sterility in males32). 
Male germ cells mainly consist of spermatogo-
nia, spermatocytes, and spermatids. Doses that 
cause death of spermatocytes are higher than those 
for spermatogonia (2-3 Gy) ; while spermatids are 
not damaged by such doses, after 4-6 Gy a notice-
able decrease in the sperm count can be observed33). 
De Felice et al. reported that the susceptibility of 
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spermatogonia, spermatocytes, and spermatids to a 
single dose irradiation was < 1 Gy, 1-3 Gy, and > 3 
Gy, respectively31). 
(2)  Effects of radiation on germline DNA damage 
and minisatellite mutations
Spermatogonia are also less susceptible to DNA 
damage after exposure to ionizing radiation, and the 
minimum dose that causes detectable DNA damage 
in male germ cells is 30 Gy34). 
Tawn et al. investigated minisatellite germline 
mutation rates in childhood and young adult cancer 
survivors who received radiotherapy and reported 
no significant difference between subsequent pater-
nal mutation rates of 5.6% in exposed fathers with a 
mean preconception testicular dose of 1.23 Gy ver-
sus 5.8% in unexposed fathers. Furthermore, the 
maternal mutation rates of 1.6% in cancer-surviving 
mothers with a mean preconception ovarian dose of 
0.58 Gy versus 2.1% in unexposed mothers were 
also not significantly different. These results indi-
cate that preconception radiotherapy for childhood 
or early adulthood cancer does not increase the 
germline minisatellite mutation rate35). The same 
groups also investigated germline minisatellite mu-
tation rates in male workers who were occupational-
ly exposed to radiation at the Sellafield nuclear facil-
ity and showed no significant difference between the 
paternal mutation rate of 5.0% for control fathers 
with a mean preconception testicular dose of 9 mSv 
and that of 5.8% for exposed fathers with a mean 
preconception testicular dose of 194 mSv. These 
results indicate that such exposures did not destabi-
lize the germline passed on to future generations36).
2) Radiation and steroidogenesis
In considering the association between radia-
tion exposure and incidence of cryptorchidism, the 
effects of radiation exposure on steroidogenesis, es-
pecially testosterone production, is most important, 
because testosterone induces testicular descent in 
utero. Leydig cells of the testis, which secrete tes-
tosterone, are remarkably more radio-resistant than 
the germinal epithelium and are only injured by high 
therapeutic radiation doses37). Furthermore, Ley-
dig cell function is usually preserved up to 20 Gy in 
prepubertal boys and 30 Gy in sexually mature 
men31).
Animal studies
(1)  Effect of local radiation exposure to the testes 
on steroidogenesis
Delic et al. reported that local radiation expo-
sure to the testes induced Leydig cell dysfunction, 
as indicated by increased serum luteinizing hormone 
(LH, to a maximum of 385% of control after 5 Gy) 
and decreased serum testosterone (to a minimum of 
30% of the control after 10 Gy) at 8 weeks post-irra-
diation21). The dysfunction, with a threshold of ap-
proximately 4 to 5 Gy, was associated with a loss of 
Leydig cells from the testis21). This group also ex-
amined dose- and time-response relationships mea-
sured after local X irradiation of 1 to 20 Gy to puber-
tal rat testes and demonstrated that the threshold 
dose for Leydig cell dysfunction was approximately 
5 Gy38). Dysfunction after higher doses was ob-
served by 2 weeks post-irradiation as a dose-depen-
dent decrease in serum testosterone concentrations, 
and the levels were undetectable after 15 or 20 
Gy38). Foppiani et al. demonstrated that bilateral 
testicular irradiation (2 Gy) increased follicle-stimu-
lating hormone (FSH) levels and, to a lesser degree, 
testosterone levels, within several weeks of irradia-
tion in adult cynomolgus monkeys25). Laporte et al. 
reported that the plasma FSH, LH, prolactin, and 
testosterone levels of adult rats with testicles ex-
posed to radiocobalt (0.8 Gy) did not change signifi-
cantly compared to controls39).
(2)  Effect of whole-body radiation exposure on ste-
roidogenesis
Pinon-Lataillade et al. examined the effect of 
continuous whole-body low-dose gamma irradiation 
at a dose-rate of 0.07 Gy/day for 92 days on plasma 
LH, FSH, and testosterone concentrations and tes-
ticular histology in rats40). They demonstrated no 
significant changes in LH and testosterone concen-
tration, although a significant increase in plasma 
FSH concentration occurred after the numbers of 
spermatogonia and preleptotene spermatocytes had 
been reduced40).
Human studies 
Some previous studies have shown effects of 
direct radiation exposure to the testis on steroido-
genesis in humans. Acute testicular irradiation to 
healthy normal men at doses between 0.08 and 6 Gy 
resulted in no statistical change in plasma testoster-
one level, although increased plasma LH levels and 
disturbance of spermatogenesis were observed after 
high dose radiation exposure (0.75 and 6 Gy)41). 
Furthermore, high dose radiation to the remaining 
testis after unilateral orchiectomy (27.5-30 Gy) dur-
ing childhood (1-4 years) greatly increased FSH and 
LH levels, with a median basal testosterone level 
that was significantly lower than that observed in 
adulthood42). 
Silvakumar et al. demonstrated that fractioned 
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gamma radiation exposure (2, 4, 6, 8, and 10 Gy) 
caused adverse effects on cultured human Leydig 
cell steroidogenesis in vitro in a dose-dependent 
manner43). While lower doses (2 and 4 Gy) were 
ineffective, higher doses (6 Gy and above) drastically 
decreased LH receptor levels, basal and LH-stimu-
lated cAMP generation, and basal, LH-, and cAMP-
stimulated steroidogenesis ; as a result, they con-
cluded that higher doses of radiation impair Leydig 
cell steroidogenesis by affecting LH signal transduc-
tion at the level of both pre- and post-cAMP genera-
tion43). 
Radiotherapy of rectal carcinoma causes collat-
eral damage to testes44,45). The mean cumulative 
radiation exposure to testicles during a course of 
pelvic radiotherapy (50 Gy) is 3.56 Gy44). Mean LH 
and FSH levels significantly increased after therapy 
(350% and 185% of pre-treatment values, respec-
tively), while testosterone levels decreased to 
78%44). After radiotherapy, the absolute risk in-
crease was 0.17-0.30 for posttreatment testosterone 
levels below 8 nmol/L45). Shapiro et al. examined 
serum LH, FSH, and testosterone levels in 27 males 
with soft-tissue sarcoma who were treated with 
high-dose radiation (from 0.01 to 24 Gy) to the tu-
mor bed and showed a dose-dependent increase in 
serum FSH and LH values following irradiation, al-
though no significant changes in total testosterone 
values were observed46). They concluded that sub-
tle Leydig cell dysfunction and germ cell depletion 
may occur at exposures greater than 2 Gy. Littley 
et al. studied the endocrine sequelae of total body ir-
radiation for hematological malignancy in 21 patients 
(11 male) who were treated with 10 Gy in five frac-
tions or 12 to 13.2 Gy in six fractions over 3 
days47). In their study, serum testosterone levels 
(12.4-35 nmol/L) were normal, although gonadotro-
phin-releasing hormone-stimulated gonadotrophin 
levels were elevated in all patients. 
3)  Effects of exposure of Cesium 137 (137Cs) on 
steroidogenesis : Lessons learned from the Cher-
nobyl nuclear plant accident 
The nuclear plant accidents at Chernobyl and 
Fukushima caused environmental dispersion of ra-
dionuclides including noble gases, short-lived radio-
nuclides (radioactive iodine and tellurides), and ra-
dioactive strontium and cesium. The release of 
137Cs, which has a half-life of 30.1 years, may result 
in its widespread distribution in plants and ani-
mals. The associated radiation exposure is domi-
nated by external gamma irradiation as 137Cs decays, 
and by soil-to-plant-to-human transfer of 137Cs in 
the food chain48). The presence of environmental 
137Cs after the nuclear power plant accidents at 
Chernobyl and Fukushima raises many health issues 
for the affected populations, especially if they are 
chronically exposed through the food chain49). 
137Cs contamination levels exceeding 1,480 
kBq/m2 were observed over 3,100 km2 and 272 km2 
in Chernobyl and Fukushima, respectively50). The 
area where 137Cs contamination exceeded 6,500 Bq/
L − corresponding to the maximum concentrations 
found in Belarusian milk immediately after the 
Chernobyl accident51) − was 13,000 km2 around the 
Chernobyl nuclear plant, versus 600 km2 around the 
Fukushima nuclear power plant52-54). When the en-
vironmental impacts of the nuclear accidents of 
Chernobyl and Fukushima are compared, the conse-
quences of the Chernobyl accident clearly exceed 
those of the Fukushima accident in the amount of ra-
dionuclides emitted and the relative size of highly 
contaminated and/or evacuated areas55). Food safe-
ty controls and evacuations were quickly and effi-
ciently implemented after the Fukushima Daiichi 
Nuclear Power Plant accident55), so the projected 
health effects in Fukushima are significantly lower 
than those of Chernobyl55). Thus, data from areas 
around the Chernobyl nuclear plant cannot be arbi-
trarily extrapolated to areas around the Fukushima 
Daiichi Nuclear Power plant. 
Animal studies
Several animal studies have simulated the ef-
fects of radiation exposure from the Chernobyl nu-
clear plant accident on testicular function. Grignard 
et al. examined the effects of chronic contamination 
with low doses of 137Cs on testicular steroidogenesis 
in adult rats56). In their study, rats were exposed to 
137Cs doses of 6,500 Bq/L in drinking water, to mimic 
radiological exposure in the territories around Cher-
nobyl. They showed that testosterone level was 
not affected following 137Cs ingestion, whereas the 
concentration of 17β-estradiol decreased threefold 
in adult rats exposed to 137Cs56).   The same group 
examined the effects of chronic contamination with 
low doses of 137Cs (6,500 Bq/L) in utero or from birth 
on testicular steroidogenesis in rats57). They 
showed that chronic exposure of growing rats to 
137Cs at doses found in the Chernobyl area exerted 
few effects on testicular steroidogenesis and histolo-
gy despite the presence of 137Cs in the testis, and 
that growing organisms appeared less sensitive to 
137Cs exposure than adults. They concluded that 
testicular steroidogenesis was not altered by chronic 
exposure to 137Cs Chernobyl fallout, whether in ute-
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ro or post-natal57). In their study, the testis weight 
was identical between control and contaminated 
groups, and although the testicular location was not 
described in their paper57), this was presumably nor-
mal due to its lack of mention. Manens et al. also 
examined the effect of exposure by chronic ingestion 
of 137Cs (6,500 Bq/L) and tested for 9 months in ex-
posed adult, neonatal, and fetal rats. In their study, 
the serum testosterone level was identical between 
control and contaminated adult, neonatal, and fetal 
rats49), although the blood level of 17β-estradiol only 
decreased in the adults49).   These animal studies 
show that the likelihood of effects on adult testoster-
one production from chronic exposure to 137Cs after 
the Chernobyl nuclear plant accident is extremely 
low. Furthermore, these findings also suggest that 
the effect on neonatal and fetal testosterone produc-
tion is low, given that the radio-sensitivity in neo-
nates and fetuses is lower than that in adults. 
Therefore, chronic contamination with 137Cs (6,500 
Bq/L) is not considered to affect testicular descent.
Human studies
Reproductive disorders, such as altered sperm 
parameters, were observed among liquidators (nu-
clear plant cleanup workers) in 137Cs-contaminated 
regions after the Chernobyl nuclear power plant 
accident ; these workers were estimated to have re-
ceived high doses of radiation exposure58-61). Fisch-
bein et al. reported significant changes in the ultra-
morphology of sperm heads in Chernobyl liquidators 
versus controls of similar age, but no significant dif-
ferences were observed between liquidators and 
controls with respect to sperm density, viability, 
morphology observed by light microscopy, semen 
volume, or biochemical markers59). On the other 
hand, Goncharov et al. examined hormone and se-
men parameters in liquidators exposed to 0.001-0.33 
Gy60). They showed that such exposure did not 
cause major long-lasting disruption of endocrine sta-
tus or spermatogenesis 7 ± 9 years later. Further-
more, there were no significant differences in plasma 
FSH levels between the liquidators and controls, and 
the testosterone levels in the liquidators were even 
significantly higher than in controls60). 
3. Did cryptorchidism really increase 
after the Fukushima Daiichi Nuclear 
Power Plant accident in Japan?
On 11 March 2011, a magnitude 9.0 earthquake 
off the Pacific coast of Northeastern Japan provoked 
a tsunami that breached more than 500 km of shore-
line, with run-up heights to 40 meters. The Fuku-
shima Daiichi Nuclear Power Plant suffered major 
damage from the earthquake and tsunami. All op-
erating reactors went into automatic shutdown, but 
a triple backup failure (grid, generator, and battery 
power) interrupted emergency core cooling.  Melt-
downs led to hydrogen gas explosions that released 
large volumes of radioisotopes into the environ-
ment. Thereafter, radiation exposure emerged as 
the most serious concern to residents living in the 
affected area.
According to Murase et al., “Nationwide in-
crease in cryptorchidism after the Fukushima nucle-
ar accident,” a 13.4% increase in cryptorchidism, 
based on hospital discharge rates, followed the Fu-
kushima Daiichi Nuclear Power Plant accident4). 
Their title implies that a nuclear accident directly in-
duced an increased incidence of cryptorchidism 
throughout Japan. Casual readers might readily be-
lieve that there was a direct relationship between 
radiation exposure and cryptorchidism, but as the 
authors admit, “A large amount of radionuclides 
emitted from the Fukushima was suspected to be a 
major cause but currently no evidence is available.4)” 
Thus, their provocative title does not reflect scien-
tific reality. In 2011, other numerous disasters and 
events, such as the explosive eruptions of Mt. Shin-
moedake and the avian influenza epidemic, happened 
in Japan. In spite of no evidence, why did the au-
thors only focus on the Fukushima Daiichi Nuclear 
Power Plant accident? We can grant that these 
other disasters and events are also exceedingly un-
likely to be associated with the incidence of cryptor-
chidism. In a subsequent paper, Murase et al. also 
reported a nationwide increase in complex congeni-
tal heart diseases after the Fukushima Daiichi Nu-
clear Power Plant accident62). The major problem 
in their prior paper is that a direct causal relation-
ship between the increased incidence of cryptorchi-
dism and the Fukushima Daiichi Nuclear Power 
Plant accident was not actually proven, as the au-
thors themselves admit. We strongly doubt that 
cryptorchidism actually increased after the accident 
in Japan ; as described below, we challenge the va-
lidity of their cryptorchidism analysis through six 
major points.
Prior to our six points, we call attention to Ko-
bashi et al., “Unambiguous evidence is required to 
accurately understand the health impact of nuclear 
accident”63) that challenges the report by Murase et 
al. on a putative increase in complex congenital 
heart diseases after the accident62). 
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1)  By what mechanism could the accident increase 
the incidence of cryptorchidism?
Androgens, especially testosterone from Leydig 
cells, are involved in the completion of testicular de-
scent in utero ; therefore, impaired fetal androgen 
action can result in cryptorchidism1). A number of 
reports suggest that this anomaly can be associated 
with genetic, environmental, and maternal/fetal fac-
tors. Many researchers have examined the associ-
ation between cryptorchidism and genetic altera-
tions of Homeobox A10 (HOXA10), insulin-like factor 
3 (INSL3), INSL3 receptor (LGR8/GREAT), andro-
gen receptor (AR), estrogen receptor α (ESR1), and 
Ad4BP/SF-1 genes, and have suggested that some 
of these genes may be implicated in cases of crypt-
orchidism1). In addition, several reports suggested 
an association between estrogen-mimicking EEDs 
and the incidence of cryptorchidism, because of the 
negative impact increased estrogen has on testicular 
descent in utero1). Maternal exposure to EEDs 
may be associated with abnormal migration of the 
testes in the male fetus64), although clear evidence in 
humans remains ambiguous3,65). 
Other maternal and fetal factors may be associ-
ated with cryptorchidism, including family history of 
cryptorchidism, parameters such as birth weight, 
gestational age, and size for gestational age, and ma-
ternal cola consumption or smoking during pregnan-
cy3,66,67). In spite of many such maternal and fetal 
risk factors, Murase et al. focused only on under-
weight and preterm births, which were almost con-
stant during the study period4) ; however, they did 
not exclude the effects of other factors in their pa-
per.
Quoting Murase et al., “...emotional stress and 
radioactive material would be considered as 2 main 
possible factors contributing to the increase. How-
ever, in human no association has been observed be-
tween cryptorchidism and severe emotional stress... 
although prenatal maternal stress has proved to be a 
risk factor for cryptorchidism in rats.”4) They con-
tinue, “In contrast, radioactive material released 
from the Fukushima nuclear accident may be con-
cerned considering its amount and known toxici-
ty4).” How such “toxicity” could induce cryptorchi-
dism is neither explained by Murase et al. nor 
supported by any of their citations. To the best of 
our knowledge, there is no report that shows a di-
rect association between radiation exposure and tes-
ticular descent during fetal periods. 
Assuming that a large quantity of radionuclides 
emitted from the Fukushima Daiichi Nuclear Power 
Plant was suspected to be a major cause of the in-
creased incidence of cryptorchidism, as asserted by 
Murase et al., a possible mechanism may be that ra-
diation exposure disturbed steroidogenesis, espe-
cially testosterone production, during periods critical 
for testicular descent. As described above and be-
low, the effects of radiation exposure to the testes 
are dose-dependent, and the possibility of the effects 
of low-dose radiation exposure on testosterone pro-
duction during fetal periods is extremely low. 
(1)  Possibility of external radiation exposure in Fu-
kushima Prefecture affecting the incidence of 
cryptorchidism 
According to the IAEA report on the Fukushima 
Daiichi Nuclear Power Plant accident, the release of 
radioactive materials from the Fukushima accident 
were approximately one-tenth of those from Cher-
nobyl68). In terms of cesium, the effective dose was 
also approximately one-tenth (Fig. 1)69). The Fuku-
shima Health Management Survey reported results 
for 460,408 residents in Fukushima Prefecture dur-
ing the first 4 months after the accident : 66.3% re-
ceived doses < 1 mSv, 94.9% received < 2 mSv, 
99.7% received < 5 mSv, and the maximum dose 
was 25 mSv70). Fujimura et al. also reported that 
children between the ages of 0 and 15 years (n = 
4,571) had a mean radiation dose of 1.5 mSv/year 6 
months after the disaster, 1.5 mSv/year in 2012, 1.0 
mSv/year in 2013, and 0.65 mSv/year in 2014, in Ni-
honmatsu City in Fukushima Prefecture71). Bedwell 
et al. assessed the doses received by members of the 
public in Japan following the nuclear accident at the 
Fukushima Daiichi Nuclear Power Plant and demon-
strated that across most of Japan the estimates of 
the dose were very low, and were estimated to be 
less than the annual average dose from natural back-
ground radiation in Japan72). Even in regions clos-
est to the Fukushima Daiichi Nuclear Power Plant, 
the maximum lifetime effective dose is estimated to 
be well below the cumulative natural background 
dose over the same period72). 
The exposure doses resulting from the Fuku-
shima Daiichi Nuclear Power Plant accident, as men-
tioned above, are shown in a unit of mSv. Since the 
gamma radiation exposure due to cesium was almost 
uniform throughout the whole body, it can be inter-
preted as corresponding to organ-specific exposures 
in units mGy. While the doses due to the Fukushi-
ma Daiichi Nuclear Power Plant accident were most-
ly on the order of a few mSv (mGy) or less, the dos-
es likely to cause effects on testicular function of 
humans/animals are at least on the order of a few 
hundred or thousand mGy, as reviewed above. 
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Therefore, the dose of radiation exposure resulting 
from the Fukushima Daiichi Nuclear Power Plant ac-
cident is considerably lower than that in animal stud-
ies and radiation therapy in humans that can affect 
steroidogenesis. According to the Guidelines for 
Diagnostic Imaging During Pregnancy by the Ameri-
can College of Obstetricians and Gynecologists, fetal 
risks of anomalies, growth restriction, or abortion 
have not been reported with radiation exposure less 
than 50 mGy73,74). Furthermore, the International 
Commission on Radiological Protection determined 
that 100 mGy is the threshold above which malfor-
mations may occur in newborns75), indicating that 
exposure of fetuses in utero to < 100 mGy should 
not cause teratogenicity63). According to these 
data, the possibility of external radiation exposure in 
Fukushima Prefecture inducing cryptorchidism is in-
finitesimally close to zero.
Murase et al. wrote that “the increase between 
FY (fiscal year) 2011 and FY2012 is obvious, and a 
gradual increase is observed from FY2012 to 
FY2014”4). As shown in Figure 2, the air dose of 
radiation in Fukushima Prefecture rapidly decreased 
with time76). For reference, typical air doses of ra-
diation in major cities such as Shanghai, Seoul, Sin-
gapore, Munich, Paris, and New York are 0.59, 0.09, 
0.17, 0.12, 0.10, 0.06 μSv/h, respectively77). The 
authors did not account for why the incidence was 
maintained after 2012, despite the rapid decrease in 
radiation levels in Fukushima Prefecture. Consid-
ering other possible mechanisms that may induce 
cryptorchidism after 2012, could the continued in-
crease be due to DNA damage in germ cells by the 
exposure, causing abnormalities such as cryptorchi-
dism in the next generation? In general, DNA 
damage in the male germline is associated with poor 
fertilization rates following in vivo fertilization, de-
fective preimplantation embryonic development, and 
high rates of miscarriage and morbidity in the off-
spring, including childhood cancer78). Physical fac-
tors, such as radiation exposure, can induce DNA 
damage in the mammalian germline ; however, to 
the best of our knowledge, there is no report to indi-
cate that DNA damage in the germline induces 
cryptorchidism. Boice et al. showed that radiother-
apy for cancer (gonadal dose : over 100 mSv) did not 
carry much, if any, risk for inherited genetic disease 
in offspring conceived after exposure79). Indeed, 
the rate of congenital anomalies did not increase in 
the children of atomic bomb survivors in Hiroshima 
and Nagasaki80). These data imply that radiation 
doses with potential transmissibility of germline 
Fig. 1. Effective radiation doses after the Fukushima Daiichi Nuclear Power Plant accident in 35 prefectures of Ja-
pan, compared to the dose for evacuees in three countries due to the Chernobyl accident. 
 *35 prefectures are those that Murase et al. showed in Figure 3 of their paper4). Distance between each prefec-
tural office and Fukushima Daiichi Nuclear Power Plant is also shown. First-year effective dose (averaged over 
each prefecture) after the accident86).
 #Effective dose for evacuees in 1986 (for ~8 months after the accident) 69).
*
#
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damage to offspring would have to be quite high.   As 
described above, spermatogonia are also less sus-
ceptible to the occurrence of DNA damage after ex-
posure to ionizing radiation, and the minimum dose 
that causes detectable DNA damage in male germ 
cells is 30 Gy34). In addition, the germline minisat-
ellite mutation rate was not affected in exposed fa-
thers with a mean preconception testicular dose of 
1.23 Gy, nor in exposed mothers with a mean pre-
conception ovarian dose of 0.58 Gy35). As shown in 
Figure 2, the air dose of radiation in Fukushima City 
at 10 : 00 pm on the 15th of March, April, May, June, 
July, and August in 2011 was 20.7, 1.83, 1.43, 1.40, 
1.24, and 1.15 μSv/h, respectively. Supposing that 
these mid-month doses were received 24 hours a 
day, each for 30 days, the cumulative radiation expo-
sure for 6 months could be estimated as shown :
 •   (20.7+1.83+1.43+1.40+1.24+1.15) (μSv/h) × 
24 (hours) × 30 (days) = 19.98 mSv/6 months 
Judging from previous data34-36), even this degree of 
chronic exposure − in fact, an overestimate because 
rapid exponential decay was the dominant term in 
March76) − is considered not to induce germline 
DNA damage. Therefore, the hypothesis that 
germline DNA damage could be caused by external 
radiation exposure in Fukushima Prefecture and in-
duce cryptorchidism after 2012 can be dismissed.   It 
defies reason why “a gradual increase is observed 
from FY2012 to FY2014,” even if “a large amount of 
radionuclides emitted from the Fukushima was sus-
pected to be a major cause” as Murase et al. assert4).
For reference, the average background dose re-
ceived by the general population is around 2.4 mSv/
year, which can vary depending on geology and 
altitude ; this ranges from 1 to 10 mSv/year, but can 
be more than 50 mSv/year. Exposure of airline 
crews flying a New York-Tokyo polar route amounts 
to 9 mSv/year, and the effective dose from abdominal 
& pelvic CT scans is 10 mSv81). Table 1 summariz-
es the external radiation exposure levels in each sit-
uation.
(2)  Possibility of internal radiation exposure in Fu-
kushima Prefecture affecting the incidence of 
cryptorchidism 
As described above, the maximum 137Cs con-
centrations measured in milk in Belarus immediate-
ly after the Chernobyl accident was 6,500 Bq/
L51). On the other hand, provisional regulation val-
ues for radioiodine were exceeded for ≤ 13 days 
(16-28 March 2011) in Fukushima Prefecture. 
While the maximum radioiodine level detected in tap 
water was 965 Bq/kg (equal to Bq/L) on 20 March 
2011, no tap water samples exceeded the provisional 
regulation value (200 Bq/L) for radioactive cesium 
(134Cs and 137Cs) after 31 March 201282). 
Consumer Co-operative in Fukushima Prefec-
ture measured radioactive cesium concentrations in 
the daily meals of 100 families using a gamma ray 
spectrometer (low detection limit < 1 Bq/kg), and 
showed that only 10% and 2% of families, respec-
tively, had received detectable radio-cesium concen-
trations from November 2011 to March 2012 (maxi-
mum 6.7 Bq/kg of 137Cs) and from June 2012 to 
September 2012 (maximum 1.9 Bq/kg of 137Cs, re-
spectively)83). Continuous consumption of such 
food for 1 year would result in an annual committed 
effective dose of 0.037 mSv70). Fukushima prefec-
ture measured the internal exposure dose of 184,208 
residents using a whole body counter between June 
2011 and February 2014, and showed that 99.986% 
received < 1 mSv, with the maximum dose being 3 
mSv70,84). Screening at Minamisoma City, which is 
Fig. 2. Changes in air doses of radiation in six cities 
of Fukushima Prefecture from 2011 to 201576).   
Fukushima City, Koriyama City, Shirakawa City, 
Minami Soma City, and Iwaki City are located ap-
proximately 64 km northwest, 58 km east, 81 km 
southeast, 98 km east, 24 km north, and 43 km 
southeast, respectively, of the Fukushima Daiichi 
Nuclear Power Plant. Reference values of radia-
tion levels in these cities are 0.04, 0.04-0.06, 0.04-
0.05, 0.04-0.05, 0.05, and 0.05-0.06 μSv/h, respec-
tively.
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located 23 km north of the Fukushima Daiichi Nu-
clear Power Plant, showed that approximately 17% 
of children and 38% of adults showed detectable in-
ternal exposure, with a concentration of 2.8 to 57.9 
Bq/kg (median, 11.9 Bq/kg) and 2.3 to 196.5 Bq/kg 
(median, 11.4 Bq/kg), respectively85). The commit-
ted effective dose by cesium was < 1 mSv, with the 
exception of one person at 1.07 mSv85).
In the animal study outlined above, the effect of 
chronic contamination (6,500 Bq/L) with 137Cs fol-
lowing the Chernobyl nuclear plant accident on adult 
testosterone production is low, and that on neonatal 
and fetal testosterone production is estimated to be 
extremely low, because radio-sensitivity in the neo-
nate and fetus is lower than that in an adult49,56,57). 
According to the data shown above, a dose of 137Cs 
found in Fukushima Prefecture after the accident is 
considered to be too low to affect testosterone pro-
duction. Therefore, the possibility that internal ra-
diation exposure in Fukushima prefecture induced 
cryptorchidism is also infinitesimally close to zero.
Ionizing radiation can arise from human activi-
ties or from natural sources81). Most radiation ex-
posure is from natural sources ; this includes radio-
activity in the rocks and soil of the Earth’s crust, 
radon (a radioactive gas given out by many volcanic 
rocks and uranium ore), and cosmic radiation. For 
example, radioactivities of around 4,500 Bq, 1,000 
Bq, 15 Bq, 3,000 Bq, and 30,000 Bq can be ascribed, 
respectively, to one adult human (65 Bq/kg), 1 kg of 
coffee, 1 banana, the air in a 100 m2 Australian home 
(radon), and 1 household smoke detector (containing 
americium)81). Table 2 summarizes internal radia-
tion exposure levels in each situation.
(3)  No evidence to support that both external and 
internal radiation exposure induces cryptorchi-
dism 
The 2013 United Nations Scientific Committee 
on the Effects of Atomic Radiation (UNSCEAR) re-
port on the Fukushima Daiichi Nuclear Power Plant 
accident stated that prenatal exposures from the ac-
cident were not expected to increase the incidence 
of spontaneous abortions, miscarriages, perinatal 
mortality, congenital effects, or cognitive impair-
ment86). Fukushima Health Management Survey 
data also showed that the incidence of stillbirth, pre-
term birth, low birth weight, and congenital anoma-
lies were similar to recent averages elsewhere in Ja-
pan, and concluded from a pregnancy and birth 
survey that no significant adverse outcomes were 
observed over the whole of the Fukushima Prefec-
ture after the disaster87).
In summary, there is no evidence to support 
that external and/or internal radiation exposure 
could induce cryptorchidism by a disturbance of ste-
roidogenesis or germline DNA damage after the Fu-
Table 1. External radiation exposure levels in various situations 
Received doses of 460,408 residents in Fukushima Prefecture during the first 4 months after the accident70)
66.3% < 1 mSv, 94.9% < 2 mSv, 99.7% < 5 mSv ; the maximum dose was 25 mSv
Mean radiation dose of children between the ages of 0-15 years (n = 4,571) in Nihonmatsu City of Fukushima 
Prefecture71)
1.5 mSv/year 6 months after the disaster, 1.5 mSv/year in 2012, 1.0 mSv/year in 2013, 0.65 mSv/year in 2014
The average dose received from background radiation81)
Around 2.4 mSv/year
Exposure of airline crews flying a New York-Tokyo polar route81)
9 mSv/year
Effective dose from abdominal & pelvic CT scans81)
10 mSv
Fetal risk of anomalies, growth restriction, or abortion reported in the Guidelines for Diagnostic Imaging During 
Pregnancy by ACOG73,74)
Have not been reported with a radiation exposures < 50 mGy
Possibility of occurrence of malformations in newborns suggested by ICRP75)
Threshold > 100 mGy
A unit of mSv reported as an exposure dose due to the Fukushima Daiichi nuclear plant accident can be interpreted as corre-
sponding individual organ/tissue exposures in mGy, based on nearly uniform exposure to cesium.
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kushima Daiichi Nuclear Power Plant accident. 
Furthermore, the quantity of radionuclides emitted 
from the power plant was too low to influence testic-
ular descent. Thus, at the very least, Murase et al. 
should have detailed how such low-level radionu-
clides might induce cryptorchidism, theoretically or 
empirically, if they wanted to invoke any mechanism 
other than the ones we have shown to be implausi-
ble. 
2)  Did the incidence of cryptorchidism increase 
throughout Japan?
Murase et al. reported that a nation-wide in-
crease in cryptorchidism was observed after the ac-
cident4). They showed increases in the rate of hos-
pital discharge after orchiopexy in 35 prefectures of 
Japan4). Since there are 47 prefectures in Japan, al-
most three quarters of the prefectures were includ-
ed in their study. The 35 prefectures included 
those in Southern Japan, including Fukuoka, Ka-
goshima, and Okinawa Prefectures, that are 1,052 
km, 1,161 km, and 1,773 km from the Fukushima 
Daiichi Nuclear Power Plant, as shown in Figure 1, 
which also shows radiation exposures in 35 prefec-
tures86). For comparison, the average doses for 
Chernobyl evacuees in three countries are also 
shown69). In general, a dose-response relationship 
is the effect on an organism or, more specifically, the 
risk of a defined outcome, produced by a given 
amount of an agent or a level of exposure88). A 
dose-response relationship exists when increasing 
levels of exposure are associated with either an in-
creasing or a decreasing risk of the outcome. Dem-
onstration of a dose-response relationship is consid-
ered strong evidence for causality88). Thus, if 
radiation exposure affects the incidence of cryptor-
chidism, the incidence in various prefectures should 
decrease with distance from the source of exposure, 
even if the decrease is not linear or uniform. How-
ever, Murase et al. failed to show any dose-response 
relationship in their paper. In fact, the analytical 
formula (2) described in their supplementary appen-
Table 2. Internal radiation exposure levels in various situations
Values for radioiodine in Fukushima Prefecture82)
Provisional regulation values were exceeded for ≤ 13 days (16–28 March 2011).
The maximum detected level was 965 Bq/kg (equal to Bq/L), detected on 20 March 2011.
Values for radio-cesiums (134Cs and 137Cs) after the Fukushima Daiichi nuclear plant accident82)
No tap water samples exhibited radioactivity that exceeded the provisional regulation value (200 Bq/L) as of 31 March 2012.
Radioactive cesium concentrations in the daily meals of 100 families examined by Consumer Co-operative in 
Fukushima Prefecture83)
10% of families received detectable (1 or more Bq/kg) radio-cesium (maximum 6.7 Bq/kg of 137Cs), from November 2011 to 
March 2012.
2% of families received detectable (1 or over Bq/kg) radio-cesium concentrations (maximum 1.9 Bq/kg of 137Cs), from June 
2012 to September 2012.
Annual committed effective dose assuming continuous consumption of these contaminated foods :  0.037 mSv.70)
Screening for internal exposure at Minamisoma City85)
17% of children showed detectable internal exposure of 2.8 to 57.9 Bq/kg (median, 11.9 Bq/kg).
38% of adults showed detectable internal exposure of 2.3 to 196.5 Bq/kg (median, 11.4 Bq/kg).
The committed effective dose from cesium was < 1 mSv except for one person with 1.07 mSv.
Exposure dose of 184,208 residents using whole body counting conducted by Fukushima Prefecture from June 
2011 to February 201470,84)
99.986% received < 1 mSv, with a maximum dose of 3 mSv.
Radioactivity of some natural and other materials81)
15 Bq in 1 banana
1,000 Bq in 1 kg of coffee
4,500 Bq in 1 adult human (65 Bq/kg)
30,000 Bq in 1 household smoke detector (with americium)
The maximum 137Cs concentrations measured in milk in Belarus immediately after the Chernobyl accident49)
6,500 Bq/L
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dix S1 explicitly showed that they omitted parame-
ters indicating a decreased difference in the hospital 
discharge rate with increasing distance from the Fu-
kushima Daiichi Nuclear Power Plant4). 
For reference, the whole of Japan and Fukushi-
ma Prefecture cover 378,000 km² and 13,783 km2, 
respectively, whereas the area affected by evacua-
tion orders was 370 km2, which is only 0.098% of Ja-
pan and 2.7% of Fukushima Prefecture. Thus, the 
majority of people in Japan and Fukushima Prefec-
ture were not significantly affected by accident-re-
lated radiation89). Bedwell et al. reported that in the 
north, south, and west of Japan, all estimates of the 
lifetime effective dose received by members of the 
public following the accident are very low, and in all 
cases are less than 1 mSv72). Furthermore, the es-
timated dose received in these regions is less than 
the typical Japanese and worldwide average annual 
doses from natural background of 2.1 mSv90) and 2.4 
mSv91), respectively. Across all regions of Central 
and Eastern Japan, including Fukushima Prefecture, 
they are below 10 mSv. These findings indicate 
that the majority of people in Japan were not signifi-
cantly exposed to radiation from the Fukushima Dai-
ichi Nuclear Power Plant, although Murase et al. 
concluded that “a large amount of radionuclides 
emitted from the Fukushima was suspected to be a 
major cause.”4) Such a declaration undoubtedly 
contributes to misunderstanding. 
In addition, Murase et al. also state : “A 
straightforward comparison between disaster-affect-
ed area and non-affected area seemed to be difficult 
because many residents migrated from the affected 
area4).” Figure 3A shows the actual number of peo-
ple who migrated from Fukushima Prefecture to 
other prefectures after the Fukushima Daiichi Nu-
clear Power Plant accident. The total number 
throughout Japan in fiscal year 2011 (FY2011) was 
62,70092). The population of Fukushima Prefecture 
in 2011 was 1,988,99593). Thus, only ~2% of peo-
ple living in Fukushima Prefecture migrated to other 
prefectures in 2011. Figure 3B shows specific mi-
gration patterns from Fukushima Prefecture follow-
ing the earthquake, tsunami, and nuclear crisis. 
Most people migrated from Fukushima Prefecture to 
Japan’s capital city, Tokyo (7,627 in 2011), or neigh-
boring prefectures such as Yamagata (12,944 in 
2011) and Niigata (6,762 in 2011) 92). The number 
of people who migrated to further south or west was 
extremely low. For example, the number of people 
who migrated to Kyoto, Osaka, Hiroshima, and Oki-
nawa in 2011 was 767, 838, 310, and 701, respec-
tively92). The population in Kyoto, Osaka, Hiroshi-
ma, and Okinawa in 2011 was 2,632,496, 8,865,448, 
2,855,734, and 1,401,93393), respectively, indicating 
that only 0.029, 0.0094, 0.0035, 0.005%, respectively, 
of the population in each prefecture migrated from 
Fukushima Prefecture in 2011. How could such a 
small number of people migrating from Fukushima 
Prefecture affect the incidence of cryptorchidism 
elsewhere? Such publically available data could 
have informed the analysis of Murase et al., but by 
their own admission, even a straightforward com-
parison was too difficult for them to undertake.
As described above, radiation exposure is not 
only external exposure but also internal via the food 
chain48). Murase et al. described it as follows : “Af-
ter the nuclear accident, radionuclides may have 
been distributed through the ecosystem through 
food contamination.”4) That may have been true af-
ter Chernobyl, but Japan has the world’s strictest 
standards for managing radioactive contamination of 
food, and anything exceeding those standards cannot 
be distributed. According to the Japan Food Sanita-
tion Act, derived intervention levels for radioactive 
cesium, which are the upper limits allowed for food 
to be distributed in the supply chain, are 10, 50, 50, 
and 100 Bq/kg (~Bq/L) in drinking water, milk, in-
fant foods, and general foods, respectively89). EU 
Council Regulations (Euratom) are more le-
nient : 1,000, 1,000, 400, and 1,250 Bq/kg in drink-
ing water, milk, infant food, and other food, respec-
tively. American Guidance Levels for Radionuclides 
in Domestic and Imported Foods allow 1,200 Bq/kg 
in general89). Results of Japan’s thorough monitor-
ing of agriculture, forestry, and fishery products pri-
or to shipment are announced, and very few foods 
have exceeded the standard limit (100 Bq/kg).   Nec-
essary measures are in place to ensure that foods 
are not distributed in the market if they are found to 
have exceeded the standard limit. Because of in-
tense and immediate monitoring, and the rapid de-
crease of initially high contamination levels94), foods 
in Fukushima Prefecture were very safe and remain 
so, making the possibility of internal exposure from 
food extremely low in Fukushima and throughout Ja-
pan.
Murase et al. cited two papers94,95) in their de-
scription as follows : “After the nuclear accident, ra-
dionuclides may have been distributed through the 
ecosystem through food contamination4).” Howev-
er, these two papers dispute what Murase et al. 
sought to imply. Mert et al. wrote as follows : “It 
seems very unlikely that more than very few mem-
bers of the public in Japan exceeded the maximum 
permissible internal exposure of 1 mSv/year. This 
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observation is in agreement with the results of pre-
vious studies94).” Furthermore, Shozugawa et al. 
wrote as follows : “we can conclude that 137Cs de-
tected in remote areas 300 km or more from Fuku-
shima nuclear power plant contained activity from 
Pre-Fukushima events such as Chernobyl accident 
(1986) and atmospheric nuclear explosions (from 
1945).” 95) Therefore, Murase et al. seem to have 
misrepresented the two papers to suit their own 
ideas. In addition, Murase et al. referred to another 
two papers in the context of “...incineration of debris 
as part of the treatment of disaster waste.”96,97) In 
fact, per Iwami and Sasai97), if a dose of 1.4 Bq/m3(N) 
of 137Cs was emitted into the air by the incineration 
of debris, and people inhaled the air every day, 24 
hours a day, 365 days a year, the dose of radiation 
exposure from the air by the incineration of debris in 
a year is calculated as below. The intake air vol-
umes per day are 20 m3 and 5 m3 for an adult and a 
1-year-old child, respectively, and the inhalation 
dose coefficients of the radionuclides (effective dose 
per unit intake) are 4.6×10-9 and 5.4×10-9 Sv/Bq, 
Fig. 3. Changes in the number of emigrants from Fukushima Prefecture after the Fukushima Daiichi Nuclear Power 
Plant accident. A. Total number of Japanese emigrants. B. The number of emigrants in each prefecture.
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respectively98).
 •   Adult : 1.4 Bq/m3×20 m3×4.6×10-9 (Sv/
Bq)×365=0.047 mSv/year
 •   1-year-old child : 1.4 Bq/m3×5 m3×5.4×10-9 
(Sv/Bq)×365=0.014 mSv/year
These data indicate that the dose of radiation expo-
sure emitted into the air by the incineration of debris 
is extremely low and is unlikely to affect the inci-
dence of cryptorchidism. 
In summary, for the reasons described above, 
the hypothesis that radiation provoked an increase of 
cryptorchidism throughout Japan has no support.
3)  Was the study design appropriate? Is it correct to 
use a DPC survey database to evaluate the num-
ber of cases of cryptorchidism?
Murase et al. counted the number of orchiopex-
ies using the Diagnosis Procedure Combination 
(DPC) database, which is a national administrative 
claims and discharge database covering acute-care 
inpatients in Japan. All 82 academic hospitals in Ja-
pan are obliged to adopt this system, while commu-
nity hospitals participate on a voluntary basis. The 
DPC database contains discharge abstract and ad-
ministrative reimbursement claims data for inpatient 
episodes collected from participating hospitals. 
This database system started in Japan in 2003, and 
its use has recently spread to acute care hospitals 
and is in transition. The ratio of hospitals involved 
in the DPC survey per total hospitals is very low 
(Figure 4). This system is unsuitable to assess 
year-on-year comparisons in the number of surger-
ies performed all over Japan, and thus represents a 
serious flaw in the design setting of the research by 
Murase et al.. 
In the event that we assess the number of sur-
geries using the DPC system, as Murase et al. did, 
the majority of hospitals in Japan are exclud-
ed. Murase et al. obtained cryptorchidism dis-
charge data collected over a 6 year period from the 
DPC survey database in Japan in order to estimate 
the discharge rate after cryptorchidism surgery be-
fore and after the accident4). Only 94 hospitals in 
Japan that participated in the DPC system and re-
ported 10 or more discharges after cryptorchidism 
surgery within 6 years covering before and after the 
accident were involved in their survey. However, 
there are many more hospitals (7,528 as of 2011)4) in 
Japan, some of which are considered to have per-
formed orchiopexy, even though their number of or-
chiopexies per year is under 10. In 2008, the Min-
istry of Health, Labour, and Welfare started to 
construct a database of all electronic health insur-
ance claim data, the so-called National Database of 
Health Insurance Claims, and Specific Health 
Checkups of Japan (NDB), which currently covers 
approximately 98% of the healthcare services pro-
vided by health insurance99-101). The NDB has 
grown to become one of the largest medical databas-
es in the world100,102,103). The NDB can be a power-
ful tool to survey the status of Japanese medical care 
in the future100). According to NDB open data104), 
the total number of orchiopexies (open orchiopexy 
[segment number : K836] + laparoscopic orchio-
pexy [segment number : K836-2]) was 9,810 (9,658 
+ 152) and 9,497 (9,368 + 129) in 2014 and 2015, 
respectively, in the whole of Japan. Murase et al. 
showed, in Supplementary Table S3 of their paper, 
that the number of orchiopexies was 6,404 and 6,042 
in 2014 and 2015, respectively, in the DPC hospi-
tals. Therefore, because the NDB has recently 
covered approximately 98% of healthcare services 
provided by health insurance, the highest estimate 
of the number of orchiopexies in DPC hospitals per 
those of all hospitals in Japan in 2014 and 2015 was 
only 65.3% (6,404/9,810) and 63.6% (6,042/9,497), 
respectively. The authors claim as follows : “The 
discharge number in the DPC data reflects the actual 
number of surgeries in Japan well4)”, but their de-
Fig. 4. Changes in the number of all Japanese hospi-
tals and those involved in the DPC survey (DPC 
hospitals).
90 Y. Kojima et al.
scription is incorrect, because over 35% of orchio-
pexies were performed in non-DPC hospitals in Ja-
pan, a point that was ignored in their study. 
Although the NDB has been used in several recent 
clinical epidemiological studies105-107), it is also un-
suitable to assess the prevalence of orchiopexy be-
tween 2011 and 2012, much like the DPC database, 
because the number of claims submitted electroni-
cally from medical institutions had increased year-
by-year (1.217, 1.511, 1.619, 1.681, 1,728, 1.808, and 
1.892 billion in 2009, 2010, 2011, 2012, 2013, 2014, 
and 2015, respectively), and this system was still in 
transition between 2011 and 2012108). In addition, 
the Ministry of Health, Labour and Welfare has 
opened aggregate data to the public since 2014, after 
the disaster, with the spread of the on-line system-
atization of claims, indicating that we have only re-
cently been able to utilize the NDB data officially. 
Murase et al. estimated in their paper that the total 
number of cryptorchidism surgeries in the DPC hos-
pitals was 5,000 to 6,0004). As described previously, 
the authors estimated the number of surgeries based 
on past reports about Western people before 
2003. According to the NDB data, the number of 
orchiopexies per year was estimated to be over 
9,000, well above the estimates of Murase et al.. 
Another problem is that the registered DPC 
hospitals in their study during the observation peri-
od are not always same every year, and just because 
hospitals are categorized as performing 10 or more 
orchiopexies does not always mean that they per-
form 10 or more every year.
The basic policy for the revision of medical 
treatment fees for FY2012 announced by the Minis-
try of Health, Labor, and Welfare in Japan stated that 
steadily implementing the promotion of clinical spe-
cialization and collaboration and home medical care 
was necessary109). To this end, the Japanese gov-
ernment aspires to establish a system to ensure the 
sharing of functions between medical institutions, 
the coordination of operations, and the centralization 
of surgery in high-volume hospitals110). After the 
introduction of the DPC system, surgeries tended to 
be aggregated into high-volume hospitals adopting 
this system. Figure 5 shows the rate of patients 
referred to DPC hospitals from other hospitals to re-
ceive cryptorchidism surgery per total number of 
patients receiving cryptorchidism surgery in DPC 
hospitals from 2010 to 2017. The rate of patients 
referred to DPC hospitals from other hospitals rap-
idly increased, suggesting that the concentration of 
orchiopexies in DPC hospitals has increased (57.6% 
in 2011 to 62.0% in 2012). One of the reasons why 
orchiopexies seemed to increase during this period 
may be simply that orchiopexies were aggregated 
into DPC hospitals, most of which are high-volume 
referral centers. Murase et al. described it as fol-
lows : “Even though health-care consolidation may 
have occurred in the hospitals included in the DPC 
because of the reform of local public hospitals, the 
sudden increase between FY2011 and FY2012 can-
not be explained by such issues related to diagnosis 
and treatment or health-care consolidation.”4) This 
is incorrect because health-care consolidation and 
the reform of local public hospitals accelerate the 
centralization of surgery to high-volume hospitals 
and result in an increased number of surgeries in 
DPC hospitals. Such policies of the Ministry of 
Health, Labor, and Welfare have taken root all over 
Japan during this period.
Murase et al. declare as follows : “The number 
of discharges was multiplied by 4/3 because only 9 
months of data were available for that year in 
FY2010, 1 year before the accident.”4) This extrap-
olation may lead to incorrect results owing to the 
possibility of seasonal variability in the number of 
orchiopexies. For example, parents likely want to 
schedule elective surgery at a convenient time, such 
as summer or spring vacation. Furthermore, the 
monthly number of surgeries may vary according to 
a doctor’s schedule, which can be affected by vaca-
tions and medical meetings. Moreover, some re-
ports have proposed that cryptorchidism occurs in 
cycles according to the calendar period of birth, with 
seasonal peaks that occur between September to 
November, and again sometime between January 
and May111-113), although there is limited evidence for 
this association. Therefore, multiplying the num-
ber of discharges by 4/3 is likely to lead to an unreli-
Fig. 5. The percentage of patients referred to DPC 
hospitals from other hospitals to receive cryptor-
chidism surgery with respect to the total number 
of patients who received cryptorchidism surgery 
in DPC hospitals.
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able calculation that may underestimate the number 
of orchiopexies during the period ; thus, this ap-
proximation has no place in a proper epidemiological 
study. 
From DPC data, we created Figure 6 to show 
the change in the number of discharges after orchio-
pexy in each of 94 hospitals between FY2011 and 
FY2012. The number increased in some DPC hos-
pitals (n = 54), while it decreased in other DPC hos-
pitals (n = 34). Changes in the number of orchio-
pexies where such surgeries increased between 
FY2011 and FY2012 amounted to +623, while 
changes in the number of orchiopexies where such 
surgeries decreased amounted to −219, indicating 
that in total, +404 (+623−219) more orchiopexies 
occurred between FY2011 and FY2012. Murase et 
al. present data in their Supplementary Appendix S4 
to show that the aggregate number of discharges af-
ter cryptorchidism surgery increased from 2,837 in 
FY2011 to 3,241 in FY2012 (+404) in 94 DPC hospi-
tals. A notable point is that the number of surger-
ies in 4 hospitals rapidly increased by 237 from 
FY2011 to FY2012 : +92 at Juntendo University 
Hospital in Tokyo, +55 at Fukuoka Children’s Hos-
pital in Fukuoka, +45 at Dokkyo Medical University 
Koshigaya Hospital in Saitama, and +45 in Saga-ken 
Medical Centre Koseikan in Saga. These data indi-
cate that surgeries in just 4 of 94 hospitals accounted 
for a large percentage (+237/+404 = 59%) of the 
total increase between FY 2011 and FY2012. In 
other words, the increased number in four major 
hospitals strongly influenced the overall difference 
between FY2011 and FY2012, thus casting doubt on 
a “nationwide increase in cryptorchidism after the 
Fukushima nuclear accident.” Furthermore, since 
these four hospitals are far removed from the nucle-
ar plant (Fig. 1 : 227 km, 1,052 km, 213 km, and 
1,080 km, respectively), where exposure to acciden-
tal radiation has been minimal, a causal relationship 
between the accident and any increase in the num-
ber of orchiopexies in these hospitals is quite un-
likely. While the numbers attributed to these four 
hospitals warrant further analysis, in the meantime 
the data imply a concentration of orchiopexy cases in 
DPC hospitals during the period of study.
In summary, for the above-described reasons, 
in order to assess the incidence of cryptorchidism 
before and after the accident, the design setting, 
analyses, and interpretation by Murase et al. using 
the DPC system falls short of the necessary rigor.
4)  Why did the number of orchiopexies in boys aged 
3-5 years old increase after the Fukushima Dai-
ichi Nuclear Power Plant accident?
Murase et al. showed age distributions of pa-
tients discharged after cryptorchidism surgery in 
DPC-participating hospitals between FY2010 and 
FY2015 in their Supplementary Table S34). From 
this data, we created Figure 7, which shows the 
change in the number of discharges after cryptorchi-
dism surgery in each age class (0-2, 3-5, and 6-15 
years old). As they described, the number of pa-
tients age 0-2 and age 3-5 increased from FY2011 to 
FY2012 by 27% and 34%, respectively. The pa-
tients of age 3-5 in FY2012 were born in FY2007 to 
FY2009, which is before the 2011 accident. As de-
Fig. 6. Changes in the number of discharges after cryptorchidism surgery in 94 DPC hospitals between FY2011 and 
FY20124).
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scribed above, since testicular descent is normally 
completed before birth2,3), the increase in orchiopexy 
for patients of age 3-5 in FY2012 would imply an in-
crease in cryptorchidism in FY2007 to FY2009, be-
fore the Fukushima Daiichi Nuclear Power Plant ac-
cident. Therefore, the authors should have shown 
that patients of age 3-5 in FY2012 did not increase 
in their study, if they wanted readers to believe that 
the incidence of cryptorchidism increased after the 
accident. In the same manner, patients of age of 2 
in FY2012 were born in 2010, which also precedes 
the accident. Thus, the authors should have con-
sidered only patients of age of 0-1 in their study. 
This is also one of several major limitations of their 
using the DPC system. Moreover, Murase et al. 
did not address this contradiction at all in their pa-
per4).
5)  Did the number of cases reporting only orchiopexy 
increase between 2011 and 2012 according to the 
DPC data?
Murase et al. reported the number of orchiopex-
ies as well as pediatric inguinal hernia surgeries 
from the DPC data in order to predict the number of 
tapped testes cases in their Supplementary Table 
S54). This table shows a change in the number in 
orchiopexies per 100 hospitals, as well as the num-
ber of pediatric inguinal hernia surgeries between 
FY2010 and FY2015. It is noteworthy that cryptor-
chidism and inguinal hernia surgeries both increased 
in FY2012, but it is quite curious that the authors 
did not mention the increase in inguinal hernia sur-
geries in their paper. It is extremely difficult to 
suppose that both of these conditions increased as a 
result of radiation exposure.    
Figure 8 shows the change in the number of 
surgeries in each field in the 94 DPC hospitals that 
are reported in the paper by Murase et al. The to-
tal number of surgeries in these hospitals increased 
between 2011 and 2012, and the number of surger-
ies in each field increased as well. These results 
indicate that not only orchiopexy, but also a number 
of other surgeries, increased between 2011 and 2012 
in these 94 DPC hospitals. The increased number 
of these surgeries is consistent with progress in the 
centralization of surgeries to these DPC hospitals, 
rather than any environmental effect such as radia-
tion exposure.
6)  Were there any societal changes that would affect 
the number of orchiopexies in 2012, the year after 
the accident?
As described above, the use of orchiopexy rates 
to measure the prevalence rate of cryptorchidism 
has limitations. If the orchiopexy rate is used as a 
surrogate for the cryptorchidism rate, changes in so-
cial circumstances should not be ignored as they 
may influence the number of surgeries. Murase et 
al. demonstrated one social factor, the consultation 
rate of infant health checkups, which did not 
change. However, there were at least two more 
changes of social circumstances in FY2012 − a med-
ical fee revision and a change in board certification 
practice by the Japanese Urological Association 
(JUA) − which may also have influenced the number 
of orchiopexies. The Ministry of Health, Labor, 
and Welfare revises medical treatment fees every 2 
years. In general, the medical fee revision can in-
fluence the number of surgeries from the point of 
view of hospital management. FY2012 was a year 
of medical fee revision114) ; in this year, medical re-
muneration points (medical treatment fees) for both 
open (segment number : K836) and laparoscopic or-
chiopexy (segment number : K836-2) were raised 
from 8,260 points (82,600 yen) and 24,440 points 
(244,400 yen) in FY 2011 to 8,470 points (84,700 
yen) and 31,770 points (317,700 yen) in FY2012, re-
spectively. 
In April 2012, the JUA decided to revise the 
board certification program from FY2013. Prior to 
FY2012, pediatric urological surgery, including or-
chiopexy, was compulsory training for subjects to 
gain board certification by the Japanese Board of 
Urology115). Residents were required to experience 
not only general urological surgery but also pediatric 
urological surgery in order to gain certifica-
tion ; however, it was decided in FY2012 by the JUA 
that pediatric surgery would be optional from 
FY2013. In Japan, not only pediatric urologists but 
also general urologists usually perform orchio-
pexy. Before FY2012, residents in general hospi-
Fig. 7. Changes in the number of discharges after 
cryptorchidism surgery per 100 DPC hospitals in 
each age group (0-2, 3-5, and 6-15 years) 4).
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tals were required to experience pediatric urological 
surgery in order to gain board certification. Since 
there is no established educational system specifi-
cally for pediatric urology in Japan, some general 
urologists were hesitant to educate residents in pe-
diatric surgery. However, due to the change in 
board certification requirements, there is a possibili-
ty that general urologists may more actively refer 
children with urological diseases, including cryptor-
chidism, to specialists of pediatric urology in high-
volume hospitals, such as children’s hospitals and 
university hospitals. This is partly due to the fact 
that after the JUA announcement in FY2012, they 
were not necessarily required to give their residents 
experience in pediatric urological surgery in order 
for them to gain certification. 
There is no proof that these changes in social 
circumstances influenced the number of orchiopex-
ies ; however, we wish to emphasize that, since so-
cial circumstances can influence the number of sur-
geries, it is important to collect and organize such 
information from various fields, to analyze and as-
sess its impact.
Conclusions
It is difficult clarify the prevalence of cryptor-
chidism because of complexities in design settings 
for epidemiological surveys of this disease. We 
have to take into account numerous factors, includ-
ing genetic, environmental, maternal/fetal, and social 
factors. Judging from previous reports, although 
high dose exposures of several Gy (Sv) to several 
tens of Gy (Sv) can damage testicular steroidogene-
sis and germline DNA, the possibility that single-
digit mGy (mSv) external exposures, or dozens of 
Bq/L internal exposures, could affect testicular ste-
roidogenesis during fetal testicular descent or dam-
age germline DNA is negligible. Actual radiation 
exposures arising from Japan’s earthquake, tsunami, 
and nuclear crisis were such that speculations about 
it causing cryptorchidism can be theoretically and 
empirically denied. Rather than “fishing” a single 
accident from among various events, including other 
accidents, disasters, and changes to the healthcare 
system that occurred contemporaneously, critical 
thinking requires a more comprehensive assess-
ment. We therefore reject the hypothesis that 
cryptorchidism increased anywhere in Japan because 
of the Fukushima Daiichi Nuclear Power Plant acci-
dent. Scientists, medical doctors, and other health 
care professionals, not only in Fukushima Prefecture 
but from around the world, are earnestly investigat-
ing the consequences of our compound disas-
ter. Concurrently, we are making sustained efforts 
to communicate what is known, what is not known, 
and what is believed, while clearly distinguishing 
among these three. Our duty of responsible disclo-
sure is for future generations to better understand 
and make use of what we experienced and subse-
quently learned. After the accident, reports on 
health-related outcomes emerged in public media 
Fig. 8. Changes in the number of surgeries by field in 94 DPC hospitals*
  *94 DPC hospitals were shown in the paper by Murase et al.4)
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and scientific literature. Some, unfortunately, made 
radical errors in terms of their design setting, inter-
pretation, and conclusions, and occasionally even 
lacked any scientific basis. Indeed, polls conducted 
by the National Institute of Science and Technology 
Policy showed that public trust in science in Japan 
was greatly damaged after the Fukushima Daiichi 
Nuclear Power Plant accident116). 
Science is a human undertaking that requires 
great effort, and, therefore, great motivation, but 
motivation arising from personal preconceptions or 
ideologies should not be allowed to compromise the 
accurate reporting of scientific investigations. Er-
rors of judgement, misinterpretation, and incorrect 
data can mislead the public, induce pseudoscience-
based policy-making, and send society into a state of 
confusion. We strongly believe that the responsi-
bility of scientists is to analyze and interpret facts 
correctly ; this, in due course, may advance societal 
prosperity and happiness. Mindful of this, we 
should consciously bear responsibility for the impact 
of our actions on others.
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